The Utility of BDNF Detection in Assessing Severity of Huntington’s Disease
暂无分享,去创建一个
K. Pawlicki | M. Wójcik-Pędziwiatr | A. Plewka | M. Rudzińska-Bar | Nikola Zmarzły | Agnieszka Krzak-Kubica | M. Rudziński | Klaudia Plinta | Magdalena Doręgowska-Stachera
[1] M. Wójcik-Pędziwiatr,et al. Is TGF-β1 a Biomarker of Huntington’s Disease Progression? , 2021, Journal of clinical medicine.
[2] M. Lasaga,et al. Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin , 2020, Journal of neuroinflammation.
[3] J. Corey-Bloom,et al. Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington’s Disease Patients , 2020, Frontiers in Molecular Neuroscience.
[4] P. Bekinschtein,et al. Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain , 2019, Front. Cell. Neurosci..
[5] B. Lutz,et al. ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation , 2016, Stem cell reports.
[6] Undurti N. Das,et al. Brain-derived neurotrophic factor and its clinical implications , 2015, Archives of medical science : AMS.
[7] M. de Tommaso,et al. Dysphagia in Huntington's Disease: Correlation with Clinical Features , 2015, European Neurology.
[8] M. Mihanović,et al. Brain-derived neurotrophic factor as a suicide factor in mental disorders , 2013, Acta Neuropsychiatrica.
[9] N. Jetté,et al. The incidence and prevalence of Huntington's disease: A systematic review and meta‐analysis , 2012, Movement disorders : official journal of the Movement Disorder Society.
[10] Jagan A. Pillai,et al. Clinical severity of Huntington's disease does not always correlate with neuropathologic stage , 2012, Movement disorders : official journal of the Movement Disorder Society.
[11] Eduardo D. Martín,et al. Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction , 2011, Molecular Neurodegeneration.
[12] Edward J. Wild,et al. Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease , 2011, PloS one.
[13] M. Hayden,et al. BDNF Overexpression in the Forebrain Rescues Huntington's Disease Phenotypes in YAC128 Mice , 2010, The Journal of Neuroscience.
[14] E. Cattaneo,et al. Brain-derived neurotrophic factor in neurodegenerative diseases , 2009, Nature Reviews Neurology.
[15] R. Roos,et al. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment. , 2008, General hospital psychiatry.
[16] M. MacDonald,et al. RESEARCH ARTICLE: Systematic Assessment of BDNF and Its Receptor Levels in Human Cortices Affected by Huntington's Disease , 2007, Brain pathology.
[17] S. Calza,et al. Low brain‐derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[18] E. Cattaneo,et al. Role of brain-derived neurotrophic factor in Huntington's disease , 2007, Progress in Neurobiology.
[19] G. Mengod,et al. Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's Disease , 2004, The Journal of Neuroscience.
[20] Fabrice P Cordelières,et al. Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along Microtubules , 2004, Cell.
[21] M. Egan,et al. The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.
[22] Ruoyan Chen,et al. Brain-derived Neurotrophic Factor Is Stored in Human Platelets and Released by Agonist Stimulation , 2002, Thrombosis and Haemostasis.
[23] Blair R. Leavitt,et al. Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease , 2001, Science.
[24] I. Ferrer,et al. Brain-derived neurotrophic factor in Huntington disease , 2000, Brain Research.
[25] R. Paus,et al. Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. , 1999, The American journal of pathology.
[26] William A Banks,et al. Transport of brain-derived neurotrophic factor across the blood–brain barrier , 1998, Neuropharmacology.
[27] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[28] M. Escobar,et al. Neurotrophins and synaptic plasticity. , 2013, Current topics in behavioral neurosciences.